The global Personalized Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.The personalized cell therapy is mainly developed for the treatment of high unmet need disease
This report aims to provide a comprehensive presentation of the global market for Personalized Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cell Therapy. This report contains market size and forecasts of Personalized Cell Therapy in global, including the following market information:
Global Personalized Cell Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
By Cell Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Personalized Cell Therapy include Novartis AG, Vericel Corporation, Bellicum Pharmaceuticals, MolMed SpA, Cytori Therapeutics Inc, Gilead Sciences, Inc, Celgene Corporation, Bluebird Bio and Aurora Biopharma Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Personalized Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Global Personalized Cell Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Personalized Cell Therapy Market Segment Percentages, by Type, 2022 (%)
- By Cell Type
- Hematopoietic Stem Cell
- Skeletal Muscle Stem Cell
- Mesenchymal Stem Cells
- Lymphocytes
- Others
- By Technique
- Platelet Transfusions
- Bone Marrow Transplantation
- Packed Red Cell Transfusions
- Organ Transplantation
Global Personalized Cell Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Personalized Cell Therapy Market Segment Percentages, by Application, 2022 (%)
- Cardiovascular Diseases
- Neurological Disorders
- Inflammatory Diseases
- Diabetes
- Cancer
- Others
Global Personalized Cell Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Personalized Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Personalized Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Personalized Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis AG
- Vericel Corporation
- Bellicum Pharmaceuticals
- MolMed SpA
- Cytori Therapeutics Inc
- Gilead Sciences, Inc
- Celgene Corporation
- Bluebird Bio
- Aurora Biopharma Inc
- Saneron CCEL TherapeuticsInc
- Kuur Therapeutics
- MediGene AG
- Sangamo Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Personalized Cell Therapy, market overview.
Chapter 2: Global Personalized Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Personalized Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Personalized Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Personalized Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Personalized Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Personalized Cell Therapy Overall Market Size
2.1 Global Personalized Cell Therapy Market Size: 2022 VS 2029
2.2 Global Personalized Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Personalized Cell Therapy Players in Global Market
3.2 Top Global Personalized Cell Therapy Companies Ranked by Revenue
3.3 Global Personalized Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Personalized Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Personalized Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Personalized Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Personalized Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Personalized Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Personalized Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 Hematopoietic Stem Cell
4.1.3 Skeletal Muscle Stem Cell
4.1.4 Mesenchymal Stem Cells
4.1.5 Lymphocytes
4.1.6 Others
4.2 By Type - Global Personalized Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Personalized Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Personalized Cell Therapy Revenue, 2024-2029
4.2.3 By Type - Global Personalized Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Personalized Cell Therapy Market Size, 2022 & 2029
5.1.2 Cardiovascular Diseases
5.1.3 Neurological Disorders
5.1.4 Inflammatory Diseases
5.1.5 Diabetes
5.1.6 Cancer
5.1.7 Others
5.2 By Application - Global Personalized Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Personalized Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Personalized Cell Therapy Revenue, 2024-2029
5.2.3 By Application - Global Personalized Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Personalized Cell Therapy Market Size, 2022 & 2029
6.2 By Region - Global Personalized Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Personalized Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Personalized Cell Therapy Revenue, 2024-2029
6.2.3 By Region - Global Personalized Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Personalized Cell Therapy Revenue, 2018-2029
6.3.2 US Personalized Cell Therapy Market Size, 2018-2029
6.3.3 Canada Personalized Cell Therapy Market Size, 2018-2029
6.3.4 Mexico Personalized Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Personalized Cell Therapy Revenue, 2018-2029
6.4.2 Germany Personalized Cell Therapy Market Size, 2018-2029
6.4.3 France Personalized Cell Therapy Market Size, 2018-2029
6.4.4 U.K. Personalized Cell Therapy Market Size, 2018-2029
6.4.5 Italy Personalized Cell Therapy Market Size, 2018-2029
6.4.6 Russia Personalized Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Personalized Cell Therapy Market Size, 2018-2029
6.4.8 Benelux Personalized Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Personalized Cell Therapy Revenue, 2018-2029
6.5.2 China Personalized Cell Therapy Market Size, 2018-2029
6.5.3 Japan Personalized Cell Therapy Market Size, 2018-2029
6.5.4 South Korea Personalized Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Personalized Cell Therapy Market Size, 2018-2029
6.5.6 India Personalized Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Personalized Cell Therapy Revenue, 2018-2029
6.6.2 Brazil Personalized Cell Therapy Market Size, 2018-2029
6.6.3 Argentina Personalized Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Personalized Cell Therapy Revenue, 2018-2029
6.7.2 Turkey Personalized Cell Therapy Market Size, 2018-2029
6.7.3 Israel Personalized Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Personalized Cell Therapy Market Size, 2018-2029
6.7.5 UAE Personalized Cell Therapy Market Size, 2018-2029
7 Personalized Cell Therapy Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Personalized Cell Therapy Major Product Offerings
7.1.4 Novartis AG Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Vericel Corporation
7.2.1 Vericel Corporation Company Summary
7.2.2 Vericel Corporation Business Overview
7.2.3 Vericel Corporation Personalized Cell Therapy Major Product Offerings
7.2.4 Vericel Corporation Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Vericel Corporation Key News & Latest Developments
7.3 Bellicum Pharmaceuticals
7.3.1 Bellicum Pharmaceuticals Company Summary
7.3.2 Bellicum Pharmaceuticals Business Overview
7.3.3 Bellicum Pharmaceuticals Personalized Cell Therapy Major Product Offerings
7.3.4 Bellicum Pharmaceuticals Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Bellicum Pharmaceuticals Key News & Latest Developments
7.4 MolMed SpA
7.4.1 MolMed SpA Company Summary
7.4.2 MolMed SpA Business Overview
7.4.3 MolMed SpA Personalized Cell Therapy Major Product Offerings
7.4.4 MolMed SpA Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 MolMed SpA Key News & Latest Developments
7.5 Cytori Therapeutics Inc
7.5.1 Cytori Therapeutics Inc Company Summary
7.5.2 Cytori Therapeutics Inc Business Overview
7.5.3 Cytori Therapeutics Inc Personalized Cell Therapy Major Product Offerings
7.5.4 Cytori Therapeutics Inc Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Cytori Therapeutics Inc Key News & Latest Developments
7.6 Gilead Sciences, Inc
7.6.1 Gilead Sciences, Inc Company Summary
7.6.2 Gilead Sciences, Inc Business Overview
7.6.3 Gilead Sciences, Inc Personalized Cell Therapy Major Product Offerings
7.6.4 Gilead Sciences, Inc Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Gilead Sciences, Inc Key News & Latest Developments
7.7 Celgene Corporation
7.7.1 Celgene Corporation Company Summary
7.7.2 Celgene Corporation Business Overview
7.7.3 Celgene Corporation Personalized Cell Therapy Major Product Offerings
7.7.4 Celgene Corporation Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Celgene Corporation Key News & Latest Developments
7.8 Bluebird Bio
7.8.1 Bluebird Bio Company Summary
7.8.2 Bluebird Bio Business Overview
7.8.3 Bluebird Bio Personalized Cell Therapy Major Product Offerings
7.8.4 Bluebird Bio Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Bluebird Bio Key News & Latest Developments
7.9 Aurora Biopharma Inc
7.9.1 Aurora Biopharma Inc Company Summary
7.9.2 Aurora Biopharma Inc Business Overview
7.9.3 Aurora Biopharma Inc Personalized Cell Therapy Major Product Offerings
7.9.4 Aurora Biopharma Inc Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Aurora Biopharma Inc Key News & Latest Developments
7.10 Saneron CCEL Therapeutics?Inc
7.10.1 Saneron CCEL Therapeutics?Inc Company Summary
7.10.2 Saneron CCEL Therapeutics?Inc Business Overview
7.10.3 Saneron CCEL Therapeutics?Inc Personalized Cell Therapy Major Product Offerings
7.10.4 Saneron CCEL Therapeutics?Inc Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Saneron CCEL Therapeutics?Inc Key News & Latest Developments
7.11 Kuur Therapeutics
7.11.1 Kuur Therapeutics Company Summary
7.11.2 Kuur Therapeutics Business Overview
7.11.3 Kuur Therapeutics Personalized Cell Therapy Major Product Offerings
7.11.4 Kuur Therapeutics Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 Kuur Therapeutics Key News & Latest Developments
7.12 MediGene AG
7.12.1 MediGene AG Company Summary
7.12.2 MediGene AG Business Overview
7.12.3 MediGene AG Personalized Cell Therapy Major Product Offerings
7.12.4 MediGene AG Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 MediGene AG Key News & Latest Developments
7.13 Sangamo Therapeutics
7.13.1 Sangamo Therapeutics Company Summary
7.13.2 Sangamo Therapeutics Business Overview
7.13.3 Sangamo Therapeutics Personalized Cell Therapy Major Product Offerings
7.13.4 Sangamo Therapeutics Personalized Cell Therapy Revenue in Global Market (2018-2023)
7.13.5 Sangamo Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Personalized Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Personalized Cell Therapy Market Drivers in Global Market
Table 3. Personalized Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Personalized Cell Therapy in Global Market
Table 5. Top Personalized Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Personalized Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Personalized Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Personalized Cell Therapy Product Type
Table 9. List of Global Tier 1 Personalized Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Personalized Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Personalized Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Personalized Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Personalized Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Personalized Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Personalized Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Personalized Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Personalized Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Personalized Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Personalized Cell Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Personalized Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Personalized Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Personalized Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Personalized Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Personalized Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Personalized Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Personalized Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Personalized Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Personalized Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Personalized Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Novartis AG Company Summary
Table 31. Novartis AG Personalized Cell Therapy Product Offerings
Table 32. Novartis AG Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Vericel Corporation Company Summary
Table 35. Vericel Corporation Personalized Cell Therapy Product Offerings
Table 36. Vericel Corporation Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Vericel Corporation Key News & Latest Developments
Table 38. Bellicum Pharmaceuticals Company Summary
Table 39. Bellicum Pharmaceuticals Personalized Cell Therapy Product Offerings
Table 40. Bellicum Pharmaceuticals Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Bellicum Pharmaceuticals Key News & Latest Developments
Table 42. MolMed SpA Company Summary
Table 43. MolMed SpA Personalized Cell Therapy Product Offerings
Table 44. MolMed SpA Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. MolMed SpA Key News & Latest Developments
Table 46. Cytori Therapeutics Inc Company Summary
Table 47. Cytori Therapeutics Inc Personalized Cell Therapy Product Offerings
Table 48. Cytori Therapeutics Inc Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Cytori Therapeutics Inc Key News & Latest Developments
Table 50. Gilead Sciences, Inc Company Summary
Table 51. Gilead Sciences, Inc Personalized Cell Therapy Product Offerings
Table 52. Gilead Sciences, Inc Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Gilead Sciences, Inc Key News & Latest Developments
Table 54. Celgene Corporation Company Summary
Table 55. Celgene Corporation Personalized Cell Therapy Product Offerings
Table 56. Celgene Corporation Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Celgene Corporation Key News & Latest Developments
Table 58. Bluebird Bio Company Summary
Table 59. Bluebird Bio Personalized Cell Therapy Product Offerings
Table 60. Bluebird Bio Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Bluebird Bio Key News & Latest Developments
Table 62. Aurora Biopharma Inc Company Summary
Table 63. Aurora Biopharma Inc Personalized Cell Therapy Product Offerings
Table 64. Aurora Biopharma Inc Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Aurora Biopharma Inc Key News & Latest Developments
Table 66. Saneron CCEL Therapeutics?Inc Company Summary
Table 67. Saneron CCEL Therapeutics?Inc Personalized Cell Therapy Product Offerings
Table 68. Saneron CCEL Therapeutics?Inc Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Saneron CCEL Therapeutics?Inc Key News & Latest Developments
Table 70. Kuur Therapeutics Company Summary
Table 71. Kuur Therapeutics Personalized Cell Therapy Product Offerings
Table 72. Kuur Therapeutics Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Kuur Therapeutics Key News & Latest Developments
Table 74. MediGene AG Company Summary
Table 75. MediGene AG Personalized Cell Therapy Product Offerings
Table 76. MediGene AG Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. MediGene AG Key News & Latest Developments
Table 78. Sangamo Therapeutics Company Summary
Table 79. Sangamo Therapeutics Personalized Cell Therapy Product Offerings
Table 80. Sangamo Therapeutics Personalized Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Sangamo Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Personalized Cell Therapy Segment by Type in 2022
Figure 2. Personalized Cell Therapy Segment by Application in 2022
Figure 3. Global Personalized Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Personalized Cell Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Personalized Cell Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Personalized Cell Therapy Revenue in 2022
Figure 8. By Type - Global Personalized Cell Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Personalized Cell Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Personalized Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Personalized Cell Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Personalized Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Personalized Cell Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Personalized Cell Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Personalized Cell Therapy Revenue Market Share, 2018-2029
Figure 16. US Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Personalized Cell Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Personalized Cell Therapy Revenue Market Share, 2018-2029
Figure 28. China Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Personalized Cell Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Personalized Cell Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Personalized Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis AG Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Vericel Corporation Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bellicum Pharmaceuticals Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. MolMed SpA Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cytori Therapeutics Inc Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Gilead Sciences, Inc Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Celgene Corporation Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bluebird Bio Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Aurora Biopharma Inc Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Saneron CCEL Therapeutics?Inc Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Kuur Therapeutics Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. MediGene AG Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sangamo Therapeutics Personalized Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
